Pelvic floor muscle rehabilitation for patients with lifelong premature ejaculation: a novel therapeutic approach
- PMID: 24883105
- PMCID: PMC4003840
- DOI: 10.1177/1756287214523329
Pelvic floor muscle rehabilitation for patients with lifelong premature ejaculation: a novel therapeutic approach
Abstract
Objectives: Premature ejaculation is the most common male sexual disorder. The aim of the study was to evaluate the possible therapeutic role of pelvic floor muscle rehabilitation in patients affected by lifelong premature ejaculation.
Methods: We treated 40 men with lifelong premature ejaculation, reporting, a baseline intravaginal ejaculatory latency time (IELT) ≤ 1 min, with 12-week pelvic floor muscle rehabilitation.
Results: At the end of the rehabilitation, mean IELTs were calculated to evaluate the effectiveness of the therapy. At the end of the treatment, 33 (82.5%) of the 40 patients gained control of their ejaculatory reflex, with a mean IELT of 146.2 s (range: 123.6-152.4 s). A total of 13 out of 33 (39%) patients were evaluated at 6 months follow up, and they maintained a significant IELT (112.6 s) compared with their initial IELT (mean 39.8 s).
Conclusions: The results obtained in our subjects treated with pelvic floor rehabilitation are promising. This therapy represents an important cost reduction compared with the standard treatment (selective serotonin reuptake inhibitors). Based on the present data, we propose pelvic floor muscle rehabilitation as a new, viable therapeutic option for the treatment of premature ejaculation.
Keywords: biofeedback; electro-stimulation; intravaginal ejaculatory latency time; premature ejaculation.
Conflict of interest statement
Figures


Similar articles
-
Pelvic muscle floor rehabilitation as a therapeutic option in lifelong premature ejaculation: long-term outcomes.Asian J Androl. 2018 Nov-Dec;20(6):572-575. doi: 10.4103/aja.aja_30_18. Asian J Androl. 2018. PMID: 29974885 Free PMC article.
-
A prospective randomized study to compare pelvic floor rehabilitation and dapoxetine for treatment of lifelong premature ejaculation.Int J Androl. 2012 Aug;35(4):528-33. doi: 10.1111/j.1365-2605.2011.01243.x. Epub 2012 Feb 9. Int J Androl. 2012. PMID: 22320846 Clinical Trial.
-
Premature ejaculation: bother and intravaginal ejaculatory latency time in Iran.J Sex Med. 2009 Dec;6(12):3478-89. doi: 10.1111/j.1743-6109.2009.01468.x. Epub 2009 Aug 28. J Sex Med. 2009. PMID: 19732308
-
An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation.Sex Med. 2014 Jun;2(2):41-59. doi: 10.1002/sm2.27. Sex Med. 2014. PMID: 25356301 Free PMC article. Review.
-
An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation.J Sex Med. 2014 Jun;11(6):1423-41. doi: 10.1111/jsm.12524. Epub 2014 May 22. J Sex Med. 2014. PMID: 24848805 Review.
Cited by
-
Ejaculatory training lengthens the ejaculation latency and facilitates the functioning of the spinal generator for ejaculation of rats with rapid ejaculation.Int J Impot Res. 2017 Jan;29(1):35-42. doi: 10.1038/ijir.2016.42. Epub 2016 Oct 27. Int J Impot Res. 2017. PMID: 27784887
-
Transcutaneous functional electrical stimulation-a novel therapy for premature ejaculation: results of a proof of concept study.Int J Impot Res. 2020 Jul;32(4):440-445. doi: 10.1038/s41443-019-0207-y. Epub 2019 Sep 30. Int J Impot Res. 2020. PMID: 31570825 Clinical Trial.
-
Pelvic physical therapy for male sexual disorders: a narrative review.Int J Impot Res. 2025 Feb 27. doi: 10.1038/s41443-025-01034-5. Online ahead of print. Int J Impot Res. 2025. PMID: 40016382 Review.
-
Current and emerging treatment options for premature ejaculation.Nat Rev Urol. 2022 Nov;19(11):659-680. doi: 10.1038/s41585-022-00639-5. Epub 2022 Aug 25. Nat Rev Urol. 2022. PMID: 36008555 Review.
-
Surgical treatment of premature ejaculation: a narrative review.Int J Impot Res. 2024 Aug;36(5):474-479. doi: 10.1038/s41443-023-00771-9. Epub 2023 Oct 5. Int J Impot Res. 2024. PMID: 37798540 Review.
References
-
- Althof S. (2006) Prevalence, characteristics and implications of premature ejaculation/rapid ejaculation. J Urol 175: 842–848 - PubMed
-
- Buvat J., Tesfaye F., Rothman M., Rivas D., Giuliano F. (2009) Dapoxetine for the treatment of premature ejaculation: results from a randomized, double blind, placebo-controlled phase three trial in 22 countries. Eur Urol 55: 957–968 - PubMed
-
- Carson C., Gunn K. (2006) Premature ejaculation: definition and prevalence. Int J Impot Res 18: S5–S13 - PubMed
-
- Jannini E., McMahon C., Chen J., Aversa A., Perelman M. (2011) The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation. J Sex Med 8: 2135–2143 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical